市場調査レポート
商品コード
1128138

米国の体外診断薬市場:Medtech 360

In Vitro Diagnostics | Medtech 360 | Market Insights | United States

出版日: | 発行: Clarivate | ページ情報: 英文 | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.52円
米国の体外診断薬市場:Medtech 360
出版日: 2022年09月21日
発行: Clarivate
ページ情報: 英文
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 目次
概要

COVID-19のパンデミックは米国の体外診断薬市場にマイナスの影響を与え、2020年には検査件数と売上高が減少しています。しかし、回復期を経て、2031年まで同市場は緩やかに成長するとみられています。これは、米国人口の高齢化、慢性疾患や感染症の発生率の上昇、価値ベースのヘルスケアへのシフトが原動力となっており、自動化された体外診断システムの開発、診断精度の向上、所要時間の短縮により、より新しい検査の普及が促進されると予想されます。

当レポートでは、米国の体外診断薬市場について調査し、市場の概要とともに、セグメント別の市場の概要と予測データ、競合動向などを提供しています。

目次

米国

概要

エグゼクティブサマリー

主なレポートの更新

COVID-19分析

  • 市場への影響
  • 主な市場予測の変化と仮定
  • 競争への影響

体外診断市場

  • 市場のハイライト
  • 市場の定義
  • 市場予測データ
  • 競争力のハイライト
  • 市場シェア
  • 競合要因と戦略
    • 臨床データ
    • 製品の改善と革新
    • 合併、買収、およびパートナーシップ
    • 製品ポートフォリオ管理
  • 市場動向

生化学検査市場

  • 市場のハイライト
  • 市場の定義
  • 市場予測データ
    • 一般化学試験
    • 糖尿病検査
    • 治療薬モニタリング試験
    • 乱用薬物検査
    • 特定のタンパク質検査
    • 心臓マーカー
    • 血液ガス
  • 競争力のハイライト
  • 市場シェア
  • 競合要因と戦略

免疫検査市場

  • 市場のハイライト
  • 市場の定義
  • 市場予測データ
    • アレルギー検査
    • 貧血検査
    • 骨代謝検査
    • 心臓マーカー検査
    • 不妊/ホルモン検査
    • 感染症検査
    • 特定タンパク質検査
    • 甲状腺検査
    • 腫瘍マーカー検査
  • 競争力のハイライト
  • 市場シェア
  • 競合要因と戦略

微生物検査市場

  • 市場のハイライト
  • 市場の定義
  • 市場予測データ
    • 病理培養検査
    • 血液培養検査
    • 同定/抗生物質感受性試験
  • 競争力のハイライト
  • 市場シェア
  • 競合要因と戦略

血液凝固検査市場

  • 市場のハイライト
  • 市場の定義
  • 市場予測データ
    • 一般的スクリーニングおよび抗凝固モニタリング検査
    • プロトロンビン時間(PT)検査
    • D-ダイマー検査
    • フィブリン形成および分解試験
  • 競争力のハイライト
  • 市場シェア
  • 競合要因と戦略

分子診断検査市場

  • 市場のハイライト
  • 市場の定義
  • 市場予測データ
    • 感染症検査
  • 競争力のハイライト
  • 市場シェア
  • 競合要因と戦略

付録

調査手法

目次

The COVID-19 pandemic has negatively impacted the US IVD market, resulting in test volumes and revenue declines in 2020. However, following a period of recovery, the market will grow modestly through 2031, driven by the aging US population, the rise in incidences of chronic and infectious, diseases and the shift toward value-based healthcare, which will fuel the uptake of newer tests with the development of automated IVD systems, improved diagnostic accuracy and reduced turnaround time. The continuous increase in the launch of IVD products being launched by key players is also fueling the growth of the market

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for IVDs in the US from 2019 through 2031.

The COVID-19 pandemic has negatively impacted the US IVD market to some extent.

  • How strongly has the US IVD market been impacted by the COVID-19 pandemic?
  • Which test types and segments have been most impacted?
  • At what pace is the market recovering?

The use of MDx tests will expand rapidly over the forecast period.

  • Which MDx tests will experience the highest growth throughout the forecast period?
  • How will adoption of MDx tests affect the other test segments in the IVD market?

The PAMA reimbursement revision will promote widespread pricing pressures and increase laboratory consolidation in the US.

  • How must vendors adjust their strategies to adapt to this trend?
  • How will the growth prospects of the market be affected?
  • How will test volumes between the different facility types be affected?

The IVD competitive landscape consists of large MNCs as well as smaller niche competitors specializing in specific segments and diseases.

  • How do strategies differ between MNCs and smaller companies in this space?
  • What are the key purchasing criteria laboratories consider when selecting an IVD manufacturer?

Table of Contents

United States

Abstract

Executive Summary

  • COVID-19 Updates
  • Market Highlights
  • Competitive Highlights
  • Market Developments
  • Procedures Covered
  • Products Covered

Key Report Updates

COVID-19 Analysis

  • Market Impact
  • Major Market Forecast Changes and Assumptions
  • Competitive Impact

In Vitro Diagnostics Market

  • Market Highlights
  • Market Definitions
  • Market Forecast Data
  • Competitive Highlights
  • Market Shares
  • Competitive Factors and Strategies
    • Clinical Data
    • Product Improvements and Innovations
    • Mergers, Acquisitions, and Partnerships
    • Product Portfolio Management
  • Market Developments

Clinical Chemistry Test Market

  • Market Highlights
  • Market Definitions
  • Market Forecast Data
    • General Chemistry Tests
    • Diabetes Tests
    • Therapeutic Drug Monitoring Tests
    • Drug of Abuse Testing
    • Specific Protein Tests
    • Cardiac Marker
    • Blood Gas
  • Competitive Highlights
  • Market Shares
  • Competitive Factors and Strategies

Immunoassay Test Market

  • Market Highlights
  • Market Definitions
  • Market Forecast Data
    • Allergy Tests
    • Anemia Tests
    • Bone Metabolism Tests
    • Cardiac Marker Tests
    • Fertility/Hormone Tests
    • Infectious Disease Tests
    • Specific Protein
    • Thyroid Tests
    • Tumor Marker Tests
  • Competitive Highlights
  • Market Shares
  • Competitive Factors and Strategies

Microbiology Test Market

  • Market Highlights
  • Market Definitions
  • Market Forecast Data
    • Pathological Culture Tests
    • Blood Culture Tests
    • Identification/Antibiotic Susceptibility Testing
  • Competitive Highlights
  • Market Shares
  • Competitive Factors and Strategies

Hematology and Coagulation Test Market

  • Market Highlights
  • Market Definitions
  • Market Forecast Data
    • General Screening and Anticoagulation Monitoring Tests
    • Prothrombin Time Tests
    • D-Dimer Tests
    • Fibrin Formation and Degradation Tests
  • Competitive Highlights
  • Market Shares
  • Competitive Factors and Strategies

Molecular Diagnostic Test Market

  • Market Highlights
  • Market Definitions
  • Market Forecast Data
    • Infectious Disease Tests
  • Competitive Highlights
  • Market Shares
  • Competitive Factors and Strategies

Appendix

  • Abbreviations
  • Bibliography

Methodology

  • Core Country Coverage Methodology
  • Research Methodology
  • Marketrack Methodology
  • PriceTrack Methodology
  • Forecast Methodology
  • Supplemental Country Coverage Methodology
  • Base-Year Ratio Analysis
  • Market Forecasting

Tables and Figures

  • Factors Impacting the IVD Market, by Application, US
  • IVD Market, by Application, US (USD), 2019-2031
  • IVD Market Landscape, US (USD), 2021 and 2031
  • Competitive Factors and Strategies, by Product Type, US
  • IVD Test Revenue Market Share Rankings, by Application, US, 2021
  • Companies Mentioned
  • Recent Events in the IVD Market, US
  • IVD Procedures Covered, US
  • IVD Products1 Covered, US
  • COVID-19 Impact Assessment Summary, IVD Market, US
  • IVD Market Scenario Forecast, US (USD), 2019-2031 (Excluding COVID-19 Impact)
  • IVD Market, by Application, US (USD), 2019-2031 (Including COVID-19 Impact)
  • COVID-19 Competitive Factors and Strategies, IVD Market, US
  • COVID-19 Financial Impact and Competitor Insights
  • Factors Impacting the IVD Market, by Application, US
  • IVD Market, by Application, US (USD), 2019-2031
  • IVD Market, by Product Type, US (USD), 2019-2031
  • IVD Market, by Setting, US (USD), 2019-2031
  • IVD Market, by Application, US (USD), 2019-2031
  • IVD Test Market, by Application, US (USD), 2019-2031
  • IVD Instrumentation Market, by Application, US (USD), 2019-2031
  • IVD Test Revenue Market Shares, US, 2021
  • IVD Test Revenue Market Shares, by Application, US, 2021
  • Competitive Factors and Strategies, by Product Type, US
  • Recent Events in the IVD Market, US
  • Clinical Chemistry Test Market, by Product Type, US (USD), 2019-2031
  • Clinical Chemistry Test Market, by Product Type, US (USD), 2019-2031
  • Clinical Chemistry Test Market, by Setting, US (USD), 2019-2031
  • Clinical Chemistry Test Market, by Test Type, US (USD), 2019-2031
  • Alanine Aminotransferase Tests, by Setting, US, 2019-2031
  • Alkaline Phosphatase Tests, by Setting, US, 2019-2031
  • Aspartate Aminotransferase Tests, by Setting, US, 2019-2031
  • Bilirubin Tests, by Setting, US, 2019-2031
  • Calcium Tests, by Setting, US, 2019-2031
  • Comprehensive Metabolic Panel Tests, by Setting, US, 2019-2031
  • Creatinine Tests, by Setting, US, 2019-2031
  • Electrolyte Panel Tests, by Setting, US, 2019-2031
  • Hepatic Panel Tests, by Setting, US, 2019-2031
  • Human Chorionic Gonadotropin Tests, by Setting, US, 2019-2031
  • Lactate Tests, by Setting, US, 2019-2031
  • Lactate Dehydrogenase Tests, by Setting, US, 2019-2031
  • Lipase Tests, by Setting, US, 2019-2031
  • Lipid Panel Tests, by Setting, US, 2019-2031
  • Magnesium Tests, by Setting, US, 2019-2031
  • Metabolic Panel including Total Calcium Tests, by Setting, US, 2019-2031
  • Phosphorus Tests, by Setting, US, 2019-2031
  • Potassium Tests, by Setting, US, 2019-2031
  • Total Protein Tests, by Setting, US, 2019-2031
  • Uric Acid Tests, by Setting, US, 2019-2031
  • Other General Chemistry Tests, by Setting, US, 2019-2031
  • Blood Glucose (Non-Reagent-Strip) Tests, by Setting, US, 2019-2031
  • Blood Glucose Reagent Strip Tests, by Setting, US, 2019-2031
  • Glucose Tolerance Tests, by Setting, US, 2019-2031
  • HbA1c Tests, by Setting, US, 2019-2031
  • Insulin Tests, by Setting, US, 2019-2031
  • Microalbumin Quantitative Tests, by Setting, US, 2019-2031
  • Urine Glucose Tests, by Setting, US, 2019-2031
  • Other Diabetes Tests, by Setting, US, 2019-2031
  • Carbamazepine Tests, by Setting, US, 2019-2031
  • Cyclosporine Tests, by Setting, US, 2019-2031
  • Digoxin Tests, by Setting, US, 2019-2031
  • Phenobarbital Tests, by Setting, US, 2019-2031
  • Phenytoin (Total) Tests, by Setting, US, 2019-2031
  • Tacrolimus Tests, by Setting, US, 2019-2031
  • Theophylline Tests, by Setting, US, 2019-2031
  • Valproic Acid (Total) Tests, by Setting, US, 2019-2031
  • Vancomycin Tests, by Setting, US, 2019-2031
  • Other TDM Tests, by Setting, US, 2019-2031
  • Ethanol Tests, by Setting, US, 2019-2031
  • Acetaminophen Tests, by Setting, US, 2019-2031
  • Salicylate Tests, by Setting, US, 2019-2031
  • Antinuclear Antibody Tests, by Setting, US, 2019-2031
  • Haptoglobin Tests, by Setting, US, 2019-2031
  • Homocysteine Tests, by Setting, US, 2019-2031
  • Prealbumin Tests, by Setting, US, 2019-2031
  • Rheumatoid Factor Tests, by Setting, US, 2019-2031
  • Somatomedin Tests, by Setting, US, 2019-2031
  • Other Specific Protein Tests, by Setting, US, 2019-2031
  • Apolipoprotein Tests, by Setting, US, 2019-2031
  • Cholesterol Tests, by Setting, US, 2019-2031
  • C-Reactive Protein Tests, by Setting, US, 2019-2031
  • High Sensitivity C-Reactive Protein Tests, by Setting, US, 2019-2031
  • Low Density Lipoprotein Tests, by Setting, US, 2019-2031
  • Triglyceride Tests, by Setting, US, 2019-2031
  • Other Cardiac Marker Tests, by Setting, US, 2019-2031
  • Arterial Blood Gas Tests, by Setting, US, 2019-2031
  • Chloride Tests, by Setting, US, 2019-2031
  • Urea Nitrogen Tests, by Setting, US, 2019-2031
  • Other Blood Gas Tests, by Setting, US, 2019-2031
  • Clinical Chemistry Test Revenue Market Shares, US, 2021
  • Clinical Chemistry Test Revenue Market Shares, by Product Type, US, 2021
  • Competitive Factors and Strategies, US
  • Immunoassay Test Market, by Product Type, US (USD), 2019-2031
  • Immunoassay Test Market, by Product Type, US (USD), 2019-2031
  • Immunoassay Test Market, by Setting, US (USD), 2019-2031
  • Immunoassay Test Market, by Test Type, US (USD), 2019-2031
  • Allergy IgA, IgD, IgG, IgM Tests, by Setting, US, 2019-2031
  • Allergy IgE Tests, by Setting, US, 2019-2031
  • Immunoglobulin Subclasses Tests, by Setting, US, 2019-2031
  • Erythropoietin Tests, by Setting, US, 2019-2031
  • Ferritin Tests, by Setting, US, 2019-2031
  • Intrinsic Factor Antibody Tests, by Setting, US, 2019-2031
  • Iron Tests, by Setting, US, 2019-2031
  • Iron Binding Capacity Tests, by Setting, US, 2019-2031
  • Vitamin B-12 Tests, by Setting, US, 2019-2031
  • HGH Tests, by Setting, US, 2019-2031
  • Parathormone Tests, by Setting, US, 2019-2031
  • Vitamin D 25 Hydroxy Tests, by Setting, US, 2019-2031
  • Creatine Kinase Tests, by Setting, US, 2019-2031
  • CK-MB Tests, by Setting, US, 2019-2031
  • BNP Tests, by Setting, US, 2019-2031
  • Troponin Tests, by Setting, US, 2019-2031
  • ACTH Tests, by Setting, US, 2019-2031
  • Estradiol Tests, by Setting, US, 2019-2031
  • FSH Tests, by Setting, US, 2019-2031
  • LH Tests, by Setting, US, 2019-2031
  • Progesterone Tests, by Setting, US, 2019-2031
  • Prolactin Tests, by Setting, US, 2019-2031
  • Testosterone Tests, by Setting, US, 2019-2031
  • Other Fertility/Hormone Tests, by Setting, US, 2019-2031
  • Acute Hepatitis Tests, by Setting, US, 2019-2031
  • CMV Tests, by Setting, US, 2019-2031
  • Epstein-Barr Virus Tests, by Setting, US, 2019-2031
  • Hepatitis A Tests, by Setting, US, 2019-2031
  • Hepatitis B Tests, by Setting, US, 2019-2031
  • Hepatitis C Tests, by Setting, US, 2019-2031
  • HIV-1/HIV-2 Tests, by Setting, US, 2019-2031
  • HSV Tests, by Setting, US, 2019-2031
  • HSV Type 2 Tests, by Setting, US, 2019-2031
  • HTLV or HIV Tests, by Setting, US, 2019-2031
  • Influenza A/B Tests, by Setting, US, 2019-2031
  • Lyme Disease Tests, by Setting, US, 2019-2031
  • Microsomal Antibodies Tests, by Setting, US, 2019-2031
  • Nephelometry Tests, by Setting, US, 2019-2031
  • Parvovirus Tests, by Setting, US, 2019-2031
  • Respiratory Syncytial Virus Tests, by Setting, US, 2019-2031
  • Rotavirus Tests, by Setting, US, 2019-2031
  • Rubella Tests, by Setting, US, 2019-2031
  • Treponema Pallidum Tests, by Setting, US, 2019-2031
  • Varicella-Zoster Virus Tests, by Setting, US, 2019-2031
  • Other Infectious Disease Tests, by Setting, US, 2019-2031
  • Albumin Tests, by Setting, US, 2019-2031
  • Alpha-1 Antitrypsin Tests, by Setting, US, 2019-2031
  • Gamma-Glutamyl Transferase Tests, by Setting, US, 2019-2031
  • Thyroxine (Free) Tests, by Setting, US, 2019-2031
  • Thyroglobulin Tests, by Setting, US, 2019-2031
  • Thyroid (T3) Tests, by Setting, US, 2019-2031
  • Thyroid (T3 or T4) Tests, by Setting, US, 2019-2031
  • Thyroxine (Total) Tests, by Setting, US, 2019-2031
  • TSH Tests, by Setting, US, 2019-2031
  • Alpha-Fetoprotein Serum Tests, by Setting, US, 2019-2031
  • Beta-2 Microglobulin Tests, by Setting, US, 2019-2031
  • CA 125 Tests, by Setting, US, 2019-2031
  • CA 15-3 Tests, by Setting, US, 2019-2031
  • CA 19-9 Tests, by Setting, US, 2019-2031
  • Carcinoembryonic Antigen Tests, by Setting, US, 2019-2031
  • PSA (Free) Tests, by Setting, US, 2019-2031
  • PSA (Total) Tests, by Setting, US, 2019-2031
  • Other Tumor Marker Tests, by Setting, US, 2019-2031
  • Immunoassay Test Revenue Market Shares, US, 2021
  • Immunoassay Test Revenue Market Shares, by Product Type, US, 2021
  • Competitive Factors and Strategies, US
  • Microbiology Test Market, by Product Type, US (USD), 2019-2031
  • Microbiology Test Market, by Product Type, US (USD), 2019-2031
  • Microbiology Test Market, by Setting, US (USD), 2019-2031
  • Microbiology Test Market, by Test Type, US (USD), 2019-2031
  • Salmonella and Shigella (Stool Culture) Tests, by Setting, US, 2019-2031
  • Other Pathogen (Stool Culture) Tests, by Setting, US, 2019-2031
  • Mycobacteria Culture Tests, by Setting, US, 2019-2031
  • Aerobic Bacterial Culture (Non-Urine, -Blood, -Stool) Tests, by Setting, US, 2019-2031
  • Anaerobic Bacterial Culture (Non-Urine, -Blood, -Stool) Tests, by Setting, US, 2019-2031
  • Urine Bacteria Culture Tests, by Setting, US, 2019-2031
  • Blood Culture Tests, by Setting, US, 2019-2031
  • Aerobic Culture Identification Tests, by Setting, US, 2019-2031
  • Anaerobic Culture Identification Tests, by Setting, US, 2019-2031
  • Immunologic Culture Identification Tests, by Setting, US, 2019-2031
  • MIC Tests, by Setting, US, 2019-2031
  • Microbe Susceptible Disk Tests, by Setting, US, 2019-2031
  • Presumptive Pathogenic Organisms Culture Tests, by Setting, US, 2019-2031
  • Yeast Identification Tests, by Setting, US, 2019-2031
  • Other ID/AST Tests, by Setting, US, 2019-2031
  • Microbiology Test Revenue Market Shares, US, 2021
  • Microbiology Test Revenue Market Shares, US, 2021
  • Competitive Factors and Strategies, US
  • Hematology and Coagulation Test Market, by Product Type, US (USD), 2019-2031
  • Hematology and Coagulation Test Market, by Product Type, US (USD), 2019-2031
  • Hematology and Coagulation Test Market, by Setting, US (USD), 2019-2031
  • Hematology and Coagulation Test Market, by Test Type, US (USD), 2019-2031
  • Automated Platelet Count Tests, by Setting, US, 2019-2031
  • Blood Smear with Differential White Blood Cell Count Tests, by Setting, US, 2019-2031
  • Complete CBC Automated Tests, by Setting, US, 2019-2031
  • Complete CBC with Automated White Blood Cell Count Tests, by Setting, US, 2019-2031
  • Erythrocyte Sedimentation Rate Tests, by Setting, US, 2019-2031
  • Hematocrit Tests, by Setting, US, 2019-2031
  • Hemoglobin Tests, by Setting, US, 2019-2031
  • Leukocyte Tests, by Setting, US, 2019-2031
  • Red Blood Cell Count Tests, by Setting, US, 2019-2031
  • Reticulocyte Tests, by Setting, US, 2019-2031
  • Sickle Cell Screen Tests, by Setting, US, 2019-2031
  • Transferrin Tests, by Setting, US, 2019-2031
  • Other General Screening and Anticoagulation Monitoring Tests, by Setting, US, 2019-2031
  • Prothrombin Time Tests, by Setting, US, 2019-2031
  • D-Dimer Tests, by Setting, US, 2019-2031
  • aPTT Tests, by Setting, US, 2019-2031
  • Fibrinogen Tests, by Setting, US, 2019-2031
  • Hematology and Coagulation Test Revenue Market Shares, US, 2021
  • Hematology and Coagulation Test Revenue Market Shares, by Product Type, US, 2021
  • Competitive Factors and Strategies, US
  • MDx Test Market, by Product Type, US (USD), 2019-2031
  • MDx Test Market, by Product Type, US (USD), 2019-2031
  • MDx Test Market, by Setting, US (USD), 2019-2031
  • Chlamydia Tests, by Setting, US, 2019-2031
  • Clostridium Difficile Tests, by Setting, US, 2019-2031
  • Gonorrhea Tests, by Setting, US, 2019-2031
  • Hepatitis C Tests, by Setting, US, 2019-2031
  • HIV-1 Tests, by Setting, US, 2019-2031
  • HPV Tests, by Setting, US, 2019-2031
  • HSV Tests, by Setting, US, 2019-2031
  • Staphylococcus Aureus Tests, by Setting, US, 2019-2031
  • Streptococcus Group A Tests, by Setting, US, 2019-2031
  • Unspecified Infectious Agent Tests, by Setting, US, 2019-2031
  • Other Infectious Disease Tests, by Setting, US, 2019-2031
  • MDx Test Revenue Market Shares, US, 2021
  • MDx Test Revenue Market Shares, by Product Type, US, 2021
  • Competitive Factors and Strategies, US
  • Abbreviations